Showing results (211-220 of 273) with videos related to
Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion scheduleA Younes, J P Ayoub, F B Hagemeister, et al.Cancer|July 21, 1998
Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family membersP Watson, K M Lin, M A Rodriguez-Bigas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 1992
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphomaJ R Redman, F Cabanillas, W S Velasquez, et al.International Journal of Radiation Oncology, Biology, Physics|November 10, 2000
Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomasP J Schlembach, R B Wilder, S L Tucker, et al.Clinical Lymphoma|November 15, 2001
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?C Visco, L J Medeiros, O M Mesina, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphomaA Younes, H A Preti, F B Hagemeister, et al.Investigational New Drugs|January 1, 1994
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomasJ E Romaguera, M A Rodriguez, F B Hagemeister, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's diseaseF B Hagemeister, L M Fuller, W S Velasquez, et al.Leukemia & Lymphoma|June 1, 1995
Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinaseS Suki, F Swan, S Tucker, et al.Leukemia & Lymphoma|June 1, 1997
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphomaA Younes, M A Rodriguez, P McLaughlin, et al.Pageof 28